Coagulation factors in nephrotic syndrome.

Area of Science:

• Nephrology
• Hematology
• Pathophysiology

Background:

• Nephrotic syndrome (NS) is linked to hemostasis disorders, including thrombocytosis, altered coagulation factors, and reduced natural anticoagulants.
• These hemostatic changes correlate with hypoalbuminemia, but their role in thromboembolic events remains unclear.
• Urinary losses of anticoagulants or increased hepatic synthesis of procoagulants contribute to clotting disturbances in NS.

Purpose of the Study:

• To investigate the role of glomerular hemostasis in nephrotic syndrome (NS) and glomerulonephritis (GN).
• To explore the potential for glomerular thrombin formation during active GN phases.
• To examine the relationship between glomerular procoagulant activity (PCA), proteinuria, and fibrin deposition.

Main Methods:

• Analysis of hemostatic parameters in patients with NS.
• Assessment of procoagulant activity (PCA) in isolated glomeruli from various GN models (human crescentic GN, rabbit nephrotoxic GN, rat HgCl2 autoimmune GN).
• Sequential studies of HgCl2-induced GN in rats to correlate glomerular PCA, proteinuria, and fibrin deposition.

Main Results:

• Glomeruli from GN models demonstrated excessive procoagulant activity (PCA).
• In HgCl2 GN, glomerular PCA, proteinuria, and fibrin deposits peaked simultaneously.
• These findings suggest immunologically mediated glomerular damage activates the extrinsic coagulation pathway.

Conclusions:

• Glomerular hemostasis activation, evidenced by PCA, occurs during active glomerulonephritis (GN) with nephrotic syndrome (NS).
• This glomerular coagulation may contribute to the pathophysiology of GN and associated thromboembolic risks.
• The extrinsic coagulation pathway is implicated in immunologically driven glomerular damage.